The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes
Jason M. Glanz(Kaiser Permanente), Frank DeStefano(Abbott Fund), Matthew F. Daley(Kaiser Permanente), David L. McClure(Marshfield Clinic), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Holly C. Groom(Kaiser Permanente Center for Health Research), Christina L. Clarke(Kaiser Permanente), Nicola P. Klein, Jo Ann Shoup(Kaiser Permanente), Elyse O. Kharbanda(HealthPartners), Simon J. Hambidge, Joshua T.B. Williams(Denver Health Medical Center), Stanley Xu(Kaiser Permanente), Bruno Lewin(Kaiser Permanente)
Cited by 11
Related Papers
The RE-AIM Framework: A Systematic Review of Use Over Time
|American Journal of Public Health|2013|1.1k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602